SCHEMBL22105261

SCHEMBL22105261

Cc1cccc(-c2ccc(NC(=O)Cn3cnc4c3C(=O)N(C)C(O)N4C)cc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSEN1 P49768 1/20 0.41
▸ PSEN2 P49810 1/20 0.41
▸ APH1B Q8WW43 1/20 0.41
▸ NCSTN Q92542 1/20 0.41
▸ APH1A Q96BI3 1/20 0.41
▸ PSENEN Q9NZ42 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ KMT2A Q03164 2/20 0.40
▸ F2 P00734 2/20 0.40
▸ F10 P00742 2/20 0.40
▸ PRSS1 P07477 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ GRIN2B Q13224 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ PORCN Q9H237 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ MAPT P10636 3/20 0.38
▸ SENP1 Q9P0U3 1/20 0.38
▸ NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22105260 0.88 KMT2A (0.46) KMT2AHTTSMN1; SMN2LMNAMEN1
SCHEMBL21935695 0.85 PORCN (0.46) F2F10PRSS1HTTSMN1; SMN2
SCHEMBL19626687 0.84 SMN1; SMN2 (0.42) THRBKMT2AF2F10PRSS1
SCHEMBL20029975 0.82 MEN1 (0.48) THRBKMT2ASMN1; SMN2MEN1MAPT
SCHEMBL19590909 0.82 KMT2A (0.47) KMT2ASMN1; SMN2LMNAMEN1MAPT
SCHEMBL22105263 0.81 PORCN (0.40) KMT2ASMN1; SMN2LMNAPORCNMEN1
SCHEMBL19626536 0.81 MAPT (0.47) KMT2ASMN1; SMN2LMNAMEN1MAPT
SCHEMBL19997366 0.81 POLB (0.46) SMN1; SMN2LMNAMAPTKDM4EALDH1A1
SCHEMBL19626637 0.80 PORCN (0.51) PORCN
SCHEMBL19626686 0.80 RAB9A (0.52) KMT2ASMN1; SMN2LMNAMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844063-B2 Purine diones as Wnt pathway modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-11-24 — — US disclosed
US-20200190086-A1 PURINE DIONES AS WNT PATHWAY MODULATORS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190086-A1 PURINE DIONES AS WNT PATHWAY MODULATORS WNT1, WNT3A, CTNNB1 PSEN1 4001/4885PSEN2 4030/4885APH1B 1778/4885
US-10844063-B2 Purine diones as Wnt pathway modulators WNT1, WNT3A, CTNNB1 PSEN1 4001/4885PSEN2 4030/4885APH1B 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback